Sera Prognostics (SERA) Non-Current Assets (2020 - 2026)
Sera Prognostics' (SERA) quarterly Non-Current Assets came in at $43.8 million in Q1 2026, down 38.2% YoY from $70.9 million in Q1 2025, and down 28.36% on a QoQ basis from $61.2 million in Q4 2025.
Sera Prognostics (SERA) Non-Current Assets (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Non-Current Assets data on file, last reported at $43.8 million in Q1 2026.
- Quarterly Non-Current Assets fell 38.2% year-over-year to $43.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $239.6 million (up 52.51% YoY) and the FY2025 annual result came in at $61.2 million, up 144.9% from the prior year.
- Non-Current Assets slipped to $43.8 million in Q1 2026, from $61.2 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $71.0 million in Q2 2025 to a low of $17.0 million in Q2 2022.
- A 5-year average of $39.4 million and a median of $33.5 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 359.77% — and 2026, when it tumbled 38.2%.
- Tracing SERA's Non-Current Assets over 5 years: stood at $26.2 million in 2022, then jumped by 30.12% to $34.1 million in 2023, then retreated by 26.75% to $25.0 million in 2024, then jumped by 144.9% to $61.2 million in 2025, then slipped by 28.36% to $43.8 million in 2026.
- The last three Non-Current Assets figures came in at $43.8 million (Q1 2026), $61.2 million (Q4 2025), and $63.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | 38.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.60 Mn |
| Mar 31, 2026 | 43.82 Mn |
| Dec 31, 2025 | 61.16 Mn |
| Sep 30, 2025 | 63.63 Mn |
| Jun 30, 2025 | 70.96 Mn |
| Mar 31, 2025 | 70.90 Mn |
| Dec 31, 2024 | 24.98 Mn |
| Sep 30, 2024 | 27.89 Mn |
| Jun 30, 2024 | 33.32 Mn |
| Mar 31, 2024 | 36.04 Mn |
| Dec 31, 2023 | 34.10 Mn |
| Sep 30, 2023 | 42.51 Mn |
| Jun 30, 2023 | 32.25 Mn |
| Mar 31, 2023 | 33.50 Mn |
| Dec 31, 2022 | 26.20 Mn |
| Sep 30, 2022 | 25.72 Mn |
| Jun 30, 2022 | 17.01 Mn |
| Mar 31, 2022 | 25.40 Mn |
| Dec 31, 2021 | 36.78 Mn |
| Sep 30, 2021 | 31.35 Mn |